NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer (2019)
Attributed to:
MICA: Stratification in COloRectal cancer: from biology to Treatment prediction: S-CORT
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21203/rs.2.13614/v1
Publication URI: http://dx.doi.org/10.21203/rs.2.13614/v1
Type: Preprint